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Dietary changes could prevent 70–80% of colorectal cancers. 
An approach to prevention could be the use of chemopreventive
agents. Many agents have been tested in animal studies, and some
are being tested in clinical trials. However, none has yet been
shown to be potent and non-toxic enough to be given to people
(Steele et al, 1998). We have previously established that a diet
supplemented with an osmotic laxative suppresses an early puta-
tive step in the development of colon cancer in rats (Corpet and
Parnaud, 1999). The putative step was the number of aberrant
crypt foci (ACF) induced by an azoxymethane injection (Bird,
1987). The laxative was polyethylene-glycol 8000 (PEG), whose
formula is H-(O-CH2-CH2)n-OH, with n = 200. PEG is the most
potent known suppressor of ACF in rats, and it also strongly
suppresses the occurrence of azoxymethane-induced cancers
(Parnaud et al, 1999; Corpet et al, 2000). The mechanism by which
PEG suppresses ACF and cancer is not known. PEG is used to
initiate cell fusion in vitro (Lentz, 1994), and we speculated that
PEG effect on membranes might play a role in chemoprevention.
We thus looked for the chemopreventive effect of polymers based
on the PEG backbone. These block copolymers combine
hydrophile and hydrophobe blocks, and vary in their surfactant
and membrane-binding properties. 
MATERIALS AND METHODS 
A total number of 158 rodents were obtained from Iffa Credo
(Lyon, France) at 4 weeks of age, and included in 4 sequential
independent studies. Rats were housed by pair in stainless steel
wire drop-bottom cages. Groups of 4 mice were housed in plastic
box cages, with sawdust bedding. Light cycle and temperature
were controlled (12 h/12 h and 22 ± 2˚C). Powdered AIN 76 diet
(UAR, Villemoisson, France) and drinking water were provided ad
libitum. After 7 days of acclimatization, each rat was given one
azoxymethane i.p. injection (20 mg kg–1 BW in saline, from Sigma
Chem, St. Quentin, France). Each mouse was given 4 weekly
injections (5 mg kg–1). 7 days later, the rodents were randomly
allocated to dietary groups. Animal care was in accordance with
the guidelines of the European Council, and rodents were killed
well before large tumours developed (UKCCCR, 1998). 
In a first study, 28 male F344 rats were randomized to 5 groups:
a control group of 12 rats fed the standard AIN 76 diet and 4
groups of 4 rats given the diet supplemented with 5% (w/w) of
one of these agents: PEG 8000 (ICN, Orsay, France), pluronic
F68 (PLU, also called poloxamer 188), polyoxyethylene 100
-stearate ester and -stearyl ether (Sigma) (Table 1). In a second
study, 30 male F344 rats were randomized to 3 groups of 10 rats
fed pellets of AIN76 diet, and drinking water pure or supple-
mented with 5% (w/v) PEG or PLU. In a third study, 60 female
OF1 mice were randomized to 3 groups of 20 mice, and treated
like the rats in the second study. In a fourth study, 40 female F344
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Table 1 Structure and main properties of PEG-like agentsa
Agent Molecular Hydrophobe Main  physical Tested 
weightb (% MW), property in study
(dalton) structurec
PEG 8000 8000 0 ===== 1–3 
PEG ester C18 4200 5 ==+ emulsifier 1 
PEG ether C18 4200 5 ==+ emulsifier 1 
PEG ether NP30 1400 15 =+ emulsifier  4 
Pluronic F68 8400 20 ==+== detergent, 
foaming 1–4 
Pluronic F127 12 600 30 ==++== gelling agent 4 
Pluronic P85 4800 50 =+= detergent, 
foaming 4 
Pluronic L64 3000 60 =+= detergent, 
o/w emulsifier 4 
Pluronic L61 2000 90 =+++= defoaming, 
w/o emulsifier 4 
aPluronic properties, according to the BASF corporation
(http://www.basf.com). 
bPolymer MW are approximate. 
cStructure is shown with = for hydrophilic and + for hydrophobic blocs. 
http://www.bjcancer.comrats were randomized to 7 groups. Two groups of 10 rats were fed
powdered AIN76 diet supplemented or not with 5% PLU. 5
groups of 4 rats were fed diets supplemented with 5% of one of
the following pluronics: F127 (Sigma), P85, L64, L61 and a PEG
nonylphenyl ether, NP30 (Synperonics from Fluka, St. Quentin,
France) (Table 1). Body weights, food and water intake were
monitored weekly. Fecal humidity was measured on pellets
obtained directly at the anus. 
30 days after the start of experimental diets, the animals were
sacrificed by carbon dioxide asphyxiation. The colons were evalu-
ated for ACF by Bird’s procedure (Bird, 1987). After fixation
between coded filter papers in 10% buffered formalin (Sigma),
they were stained with methylene blue (0.1%) for 6 min, then the
mucosal side was observed at 32 ×  magnification. ACF were
distinguished from surrounding non-involved crypts by their slit-
like opening, increased staining, size and pericryptal zone. All
colons were scored blindly by a single observer. 
Results were analysed for statistical significance with the test of
Welch. Multiple comparisons with a single control were done with
the test of Dunnet. Data are given as mean ± standard deviation.
Two-sided P values below 0.05 were considered significant. 
RESULTS 
PLU and PEG strikingly suppressed ACF in the first study (Table 2).
There were 71 times fewer ACF in PLU-fed rats than in controls 
(a 98.6% reduction, P < 0.0001), and these ACF were smaller than
in controls (P = 0.003). The difference between PEG and PLU was
not significant (P = 0.24), perhaps because groups were too small.
A small polyp was found in an azoxymethane-injected PLU-fed
rat. The treatments with PEG-ester and PEG-ether marginally
decreased the number of total ACF, and the number of large ACF.
All agents markedly increased the fecal weight and humidity
(Table 2). No agent changed the rat body weight (Table 2) or the
water and food intake (17 ± 1 ml d–1 and 17 ± 1 g d–1). 
The second and third studies confirmed the effect of PLU in
larger groups of rats and mice. Both PEG- and PLU-fed rats and
mice had fewer ACF than controls (Table 3, all P < 0.0001). In
mice, PLU treatment led to fewer ACF than PEG treatment (P =
0.0003). PLU-fed mice did not excreted more feces, or more moist
feces, than controls. Thus, in mice, the chemoprevention afforded
by PLU was not due to a laxative effect. Again, a small polyp was
found in one PLU-fed rat. PLU and PEG did not change the final
body weight of rats or mice (Table 3). Because mice drank rela-
tively more water than rats, they received twice more PEG and
PLU than rats (7.5 and 3.5 g kg–1 d–1 respectively). 
In the fourth study, PLU was very potent to suppress ACF in
female rats (Table 4). There was 56 times fewer ACF in PLU-fed
rats than in controls (P < 0.0001), and 6 PLU-fed rats out of 10 had
no ACF at all. Pluronic F127 halved the ACF number (P < 0.01),
but the other pluronics produced no significant effect on ACF
number (Table 4). The food and water intake were not changed by
the pluronics (12 ± 2 g and 13 ± 1 ml d–1), except L61 and L64.
Indeed, rats refused to eat the diet with pluronic L61 or L64, even
when, after one week, the inclusion level was lowered to 1%. This
early fast may explain the reduced ACF size in these two groups.
In contrast with the other three studies, PLU decreased the weight
gain compared with control diet (–6%, Table 4). 
DISCUSSION 
Dietary PLU strikingly suppressed ACF when administered after
carcinogen treatment. To our knowledge, PLU is the only agent
able to clear completely ACF from the colon of rats after an
azoxymethane injection (shown here in 6 female rats out of 10).
The results suggest, but do not prove, that PLU could be a more
potent agent than PEG. When PLU and PEG were directly
compared, the number of ACF was smaller in PLU-fed than in
PEG-fed rodents (Tables 2 and 3), but the difference was signifi-
cant in mice only. In addition, PLU was more potent than PEG to
decrease the number of large ACF, a better carcinogenesis end-
point than total ACF (Caderni et al, 1995). To summarize our
previous rat studies, a 30-day PEG treatment decreases the ACF
number 6-fold (median of 6 independent studies) (Corpet and
Parnaud, 1999; Parnaud et al, 1999; Corpet et al, 2000). Here, PLU
treatment decreased the ACF number 31-fold (median of 4 rat
studies). PLU was thus roughly 5 times more potent than PEG,
which is the most potent suppressing agent in this model (Corpet
and Parnaud, 1999). Two possibilities may however reduce the
value of this finding, and should be studied further: (i) PLU might
suppress ACF but not tumours, as suggested by the finding of an
occasional polyp in 2 PLU-fed rats; (ii) PLU might suppress
tumours in rodents but not in humans. 
The pluronics, or poloxamers, are a family of nonionic surface
active agents. They are block copolymers of hydrophobe propyl-
ene oxide sandwiched between two hydrophile ethylene oxide
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Table 2 Effect of feeding PEG-like compounds on azoxymethane-induced aberrant crypt foci (ACF) and fecal values in F344
rats given an AIN 76 diet 
Groupa n ACF/ Crypts/ Large ACF Fecal Water in  Rat body
colon ACF > 2 cryptsc weight (g/d) fresh feces (%) weight (g)
Control 11d 53 ± 14b 2.3 ± 0.2 17 ± 6 1.1 ± 0.1 30 ± 7 270 ± 14 
PEG 8000 4 3.7 ± 4.5* 2.2 ± 0.6  1.2 ± 1.5* 2.4 ± 0.1* 68 ± .5* 270 ± 8 
Pluronic F68 4 0.7 ± 1.0* 1.5 ± 0.7+ 0.2 ± 0.5* 2.7 ± 0.1* 64 ± .1* 268 ± 4 
PEG ester C18 4 30 ± 17 1.9 ± 0.2  6.5 ± 2.5 + 2.4 ± 0.2* 57 ± 6* 256 ± 15 
PEG ether C18 3d 57 ± 62 1.9 ± 0.1 10 ± 11 2.0 ± 0.1* 62 ± 4* 265 ± 7 
ANOVA P 0.001 0.02 <0.0001 <0.0001 <0.0001 0.36 
aDiets were supplemented with (5% w/w) PEG 8000, Pluronic F68, PEG ester C18: polyoxyethylene 100 stearate ester, and
PEG ether C18: polyoxyethylene 100 stearyl ether. bMean ± SD,* P < 0.01 and + P < 0.05 by Dunnet’s test, compared with
control group. cThreshold was chosen so that no group has 0 large ACF. dOne control rat and one PEG ether C18-fed rat died
shortly after randomization. blocks (Schmolka, 1994). 5 pluronics, PEG, and 3 other PEG-like
agents with a hydrophobe moiety, were tested here (Table 1).
Among the 9 agents we have tested, only the most water-soluble,
PEG and PLU, were very potent against ACF (Table 1). The mech-
anism by which PLU decreases colon carcinogenesis is not known.
Two mechanisms could be considered: healing of cell membranes,
and dilution of gut content. (i) PLU markedly reduces cell loss and
improves the growth of cells in culture (Swim and Parker, 1960),
possibly because it strengthens the cell membranes (Zhang et al,
1992). The polyoxypropylene hydrophobe, not present in PEG,
adheres to the hydrophobic area of the damaged cell membrane
(Schmolka, 1994). PLU can thus plug holes, or facilitate mem-
brane resealing (AlRubeai et al, 1993; Togo et al, 1999). Since cell
wounding occurs to superficial cells in the lower gut (McNeil and
Ito, 1989), we speculate that this healing effect might reduce crypt
proliferation or block ACF growth. (ii) PLU, like PEG, is an
osmotic laxative that increases fecal bulk and stools moisture,
which dilutes bile acids (Corpet and Parnaud, 1999). However,
many PEG-like agents that did not suppress ACF, increased fecal
bulk as much as PLU (Tables 2 and 4). Moreover, PLU markedly
decreased the ACF number in mice, without increasing the fecal
bulk. We thus do not think that the dilution of gut content is the
major mechanism of chemoprevention by PLU. 
In conclusion, dietary PLU strikingly suppressed azoxymethane-
induced preneoplastic lesions in the colon of rodents. PLU is not
absorbed, and its per os toxicity is very low. PLU has a long and
safe history of clinical applications, and has been given i.v. to
several hundred patients (Schmolka, 1994). Based on body area,
the protective dose in rats would translate to 20–40 g d–1 in
humans. In France, PLU is used as a common mild laxative at a
dose of 6 g d–1. PLU treatment can thus be associated with
unpleasant side-effect. If long-term animal studies show that PLU
can prevent macroscopic tumours, we think that its preventive
features might be tested in humans at risk for colon cancer. 
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